Recombinant human serum albumin-interferon-alpha-2a (Jilin university)

N/A

Report date: 2023/01/07 18:44:12

Base Information

Drug NameRecombinant human serum albumin-interferon-alpha-2a (Jilin university)
Drug Alias NamerHSA/IFNalpha2a
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJilin University
China Registration ClassN/A

Develop Information

Active CompaniesJilin University
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A